Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 7/11/2015 |
| Start Date: | October 2006 |
| End Date: | June 2014 |
| Contact: | Harold L Lazar |
| Email: | harold.lazar@bmc.org |
| Phone: | 617-638-7352 |
Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients
entGlycemic control has been found to improve clinical outcomes following Coronary Bypass
Surgery. This study tests the hypothesis that obtaining tighter glycemic
control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve
outcomes.
Surgery. This study tests the hypothesis that obtaining tighter glycemic
control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve
outcomes.
150 diabetic patients will be randomized to achieve aggressive glycemic control
(80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions
beginning at anesthetic induction and continuing for 18 hours following surgery.
(80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions
beginning at anesthetic induction and continuing for 18 hours following surgery.
Inclusion Criteria:
- All diabetic patients undergoing Coronary Bypass Surgery
Exclusion Criteria:
- Patients with hepatic and renal failure
We found this trial at
1
site
Boston Med Center Boston Medical Center (BMC) is a 496-bed academic medical center located in...
Click here to add this to my saved trials
